Evidence map›Paper›PMID 35043761›Full record

ReviewCurrent neuropharmacology2022

Neuroinflammation: The Role of Anthocyanins as Neuroprotectants.

Otilia J F Banji, David Banji, Hafiz A Makeen, Saad S Alqahtani, Saeed Alshahrani

Open access · greenAbstract readReview
In one paragraph

Review in Current neuropharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Chitosan Nanoparticle-EncapsulatedInternational journal of molecular sciences · 2025
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Otilia J F BanjiDepartment of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, KSA.
David BanjiDepartment of Pharmacology & Toxicology, College of Pharmacy, Jazan University, Jazan, KSA.
Hafiz A MakeenDepartment of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, KSA.
Saad S AlqahtaniDepartment of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, KSA.
Saeed AlshahraniDepartment of Pharmacology & Toxicology, College of Pharmacy, Jazan University, Jazan, KSA.
Jazan University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroinflammation is a trigger for several neurodegenerative and neuropsychiatric disorders. Exposure to noxious external stimuli induces homeostatic disturbances resulting in morphological changes in microglia, their activation, and elaboration of pro-inflammatory mediators. This leads to neuroinflammation with the progressive loss of neurons. Nutraceuticals such as anthocyanins are a class of brightly colored bioactive compounds present in fruits and vegetables with purported health benefits. They interfere with the activation of several signaling cascades that have a prominent role in preventing neuroinflammation. More importantly, anthocyanins can cross the blood-brain barrier and are safe. Hence, the current review focuses on the bioavailability of anthocyanins, clinical and in vitro evidence on their role in impeding the activation of transcription factors, modulating the immune milieu within the central nervous system, preventing the activation of microglia, and averting neuroinflammation.

Indexed as

Neuroprotective AgentsAnthocyaninsCentral Nervous SystemHumansInflammationMicrogliaNeuroinflammatory DiseasesAnthocyaninsNeuroprotective AgentsAnthocyaninsbioavailabilitymicroglianeuroinflammationoxidative stresssignaling pathways

Identifiers

PMID35043761
PMCPMC9886846
OpenAlexW4206306384

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.